Schrödinger to Announce Second Quarter 2024 Financial Results on July 31
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Schrödinger to Present at Jefferies Global Healthcare Conference
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Schrödinger Reports First Quarter 2024 Financial Results
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Schrödinger to Announce First Quarter 2024 Financial Results on May 1
Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Schrödinger Reports Strong Fourth Quarter and Full-Year 2023 Financial Results